Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Solventum (SOLV) Receivables (2023 - 2025)

Historic Receivables for Solventum (SOLV) over the last 3 years, with Q3 2025 value amounting to $1.2 billion.

  • Solventum's Receivables fell 1137.91% to $1.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 billion, marking a year-over-year decrease of 1137.91%. This contributed to the annual value of $1.2 billion for FY2024, which is 639.76% down from last year.
  • According to the latest figures from Q3 2025, Solventum's Receivables is $1.2 billion, which was down 1137.91% from $1.3 billion recorded in Q2 2025.
  • In the past 5 years, Solventum's Receivables ranged from a high of $1.3 billion in Q3 2024 and a low of $1.1 billion during Q1 2025
  • Its 3-year average for Receivables is $1.2 billion, with a median of $1.2 billion in 2024.
  • Over the last 5 years, Solventum's Receivables had its largest YoY gain of 470.77% in 2025, and its largest YoY loss of 1137.91% in 2025.
  • Over the past 3 years, Solventum's Receivables (Quarter) stood at $1.3 billion in 2023, then fell by 6.4% to $1.2 billion in 2024, then dropped by 4.31% to $1.2 billion in 2025.
  • Its last three reported values are $1.2 billion in Q3 2025, $1.3 billion for Q2 2025, and $1.1 billion during Q1 2025.